Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rocket Pharmaceuticals Stock (NASDAQ: RCKT) stock price, news, charts, stock research, profile.

Open	$10.99
Close	$10.47
Volume / Avg.	1.08M / 1.45M
Day Range	$10.42 - $11.08
52 Wk Range	9.33 - 31.47
Market Cap	$1.13B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	18.07%
Days to Cover	6.69

Recent News

Top 3 Health Care Stocks That Could Blast Off This Month

Avi Kapoor

3 Small-Cap Stocks That Are Ready to Rocket Higher

The Russell 2000 Index, often called the small-cap index, is up about 19.6% in 2024. Much of that gain has come in the last six months, and the clarity after the U.S. presidential election is stirring animal spirits in

MarketBeat

Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst

Rocket Pharmaceuticals reveals RP-A501 Phase 1 data for Danon disease, showing durable efficacy, reduced cardiac biomarkers, and improved heart health.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$10.99
Close	$10.47
Volume / Avg.	1.08M / 1.45M
Day Range	$10.42 - $11.08
52 Wk Range	9.33 - 31.47
Market Cap	$1.13B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	18.07%
Days to Cover	6.69

About Rocket Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the developme...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rocket Pharmaceuticals (RCKT) stock?

You can purchase shares of Rocket Pharmaceuticals (NASDAQ:RCKT) through any online brokerage.

View our list of the best stock brokerages

Who are Rocket Pharmaceuticals (RCKT) competitors?

Other companies in Rocket Pharmaceuticals’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Rocket Pharmaceuticals (RCKT) stock?

Rocket Pharmaceuticals has a consensus price target of $47.21.

What is the current price for Rocket Pharmaceuticals (RCKT)?

The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $10.66 last updated February 21, 2025 at 7:16 PM EST.

Does Rocket Pharmaceuticals (RCKT) pay a dividend?

There are no upcoming dividends for Rocket Pharmaceuticals.

When is Rocket Pharmaceuticals (NASDAQ:RCKT) reporting earnings?

Rocket Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Rocket Pharmaceuticals (RCKT) going to split?

There is no upcoming split for Rocket Pharmaceuticals.

What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Rocket Pharmaceuticals

Rocket Pharmaceuticals (RCKT) Forecast